News & Events

• Filter by:
• All
• News
• Events

• events

  November 5, 2019

  ELRIG Drug Discovery 2019

  Read more

• events

  November 3, 2019

  NCRI Cancer Conference 2019

  Read more

• events

  October 26, 2019

  AACR-NCI-EORTC

  Read more

• events

  October 22, 2019

  Targeted Protein Degradation 2019

  Read more

• events

  October 16, 2019

  What can Big Data do for Chemistry II

  Read more

• events

  October 15, 2019

  Festival of Biologics 2019

  Read more

• events

  October 10, 2019

  New Synthetic Methods II

  Read more

• events

  October 8, 2019

  10th World ADC Summit

  Read more

• news

  March 20, 2019

  Almac Discovery and Elasmogen to Share Anti-ROR-1 VNAR Data at American Association of Cancer Annual Meeting

  Read more

• news

  March 18, 2019

  Almac Discovery Showcases its Deubiquitinase Drug Discovery Expertise at the American Association of Cancer Research Annual Meeting in Atlanta

  Read more

• news

  August 6, 2018

  VNAR Based Oncology Platform in development

  Read more

• news

  July 5, 2018

  Dr. Xavier Jacq Appointed Vice President, Biology

  Read more

• news

  April 23, 2018

  Latest developments in DUB inhibitors shared at Proteasome & Autophagy Congress

  Read more

• news

  April 10, 2018

  Almac Discovery to Present at AACR 2018

  Read more

• news

  January 29, 2018

  Research Highlighted in Nature Chemical Biology

  Read more

• news

  December 4, 2017

  USP7 inhibitors from UbiPlex^TM Platform published

  Read more

• news

  September 4, 2017

  ALM201 Poster Presentation at 2017 ESMO Congress

  Read more

• news

  July 3, 2017

  ALM201 – Orphan Drug Designation Granted in Ovarian Cancer

  Read more

• news

  June 20, 2017

  Agreement with Debiopharm to Develop Novel Wee-1 Inhibitor

  Read more

• news

  May 8, 2017

  Wee-1 kinase patent approval granted

  Read more

• news

  February 14, 2017

  Therapy-resistant cancer tumors targeted with RCSI

  Read more

• news

  May 30, 2016

  Diseases of the eye explored with McClay Foundation and UU

  Read more

• news

  February 4, 2016

  Novel allosteric Akt inhibitor (ALM301) Patent Protection Secured

  Read more

• news

  October 5, 2015

  European Patent Protection for ALM201 Secured

  Read more

• news

  July 10, 2015

  Ubiquitin Specific Protease Collaboration with Genentech

  Read more

• news

  September 4, 2013

  £13m Investment Cancer Research Initiatives with QUB

  Read more

• news

  April 27, 2009

  Minister Praises Craigavon Life Sciences Firm’s Commitment to R&D

  Read more

• news

  June 10, 2008

  Almac Group Launches Oncology Discovery Arm

  Read more